1-7 of 7
Jason R. Baird
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma

Jason R. Baird, R. Bryan Bell, Victoria Troesch, David Friedman, Shelly Bambina, Gwen Kramer, Tiffany C. Blair, Terry Medler, Yaping Wu, Zhaoyu Sun, Tanja D. de Gruijl, Rieneke van de Ven, Rom S. Leidner, Marka R. Crittenden, Michael J. Gough
Journal: Cancer Research
Cancer Res (2018) 78 (21): 6308–6319.
https://doi.org/10.1158/0008-5472.CAN-18-1652
Published: 01 November 2018
View article titled, Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma
Open the PDF for Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors

Jason R. Baird, David Friedman, Benjamin Cottam, Thomas W. Dubensky, Jr., David B. Kanne, Shelly Bambina, Keith Bahjat, Marka R. Crittenden, Michael J. Gough
Journal: Cancer Research
Cancer Res (2016) 76 (1): 50–61.
https://doi.org/10.1158/0008-5472.CAN-14-3619
Published: 03 January 2016
View article titled, Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors
Open the PDF for Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors in another window
Includes: Supplementary data
Journal Articles

Abstract 1788: Converting radiation-mediated tumor control to tumor cure by manipulating the macrophage response to dying cells

Marka R. Crittenden, Jason R. Baird, Talicia Savage, Benjamin Cottam, David Friedman, Kristina Young, Pippa Newell, Cynthia Nguyen, Andrew M. Jackson, Michael J. Gough
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1788.
https://doi.org/10.1158/1538-7445.AM2015-1788
Published: 01 August 2015
View article titled, Abstract 1788: Converting radiation-mediated tumor control to tumor cure by manipulating the macrophage response to dying cells
Journal Articles

Abstract B21: Immune-based treatment of ovarian cancer in a mouse model with attenuated Toxoplasma gondii.

Steven Fiering, Jason R. Baird, Barbara Fox, Patrick Lizotte, Kiah Sanders, Jose Conjeo-Garcia, David Bzik
Journal: Cancer Research
Cancer Res (2013) 73 (1_Supplement): B21.
https://doi.org/10.1158/1538-7445.TUMIMM2012-B21
Published: 02 April 2014
View article titled, Abstract B21: Immune-based treatment of ovarian cancer in a mouse model with attenuated Toxoplasma gondii.
Journal Articles

Abstract A36: Treatment of established dermal murine B16F10 melanoma with an attenuated Toxoplasma gondii eliminates the treated tumor and stimulates systemic antitumor immunity.

Steven Fiering, Jason R. Baird, Katelyn Byrne, Patrick Lizotte, David Mullins, Mary Jo turk
Journal: Cancer Research
Cancer Res (2013) 73 (1_Supplement): A36.
https://doi.org/10.1158/1538-7445.TUMIMM2012-A36
Published: 02 April 2014
View article titled, Abstract A36: Treatment of established dermal murine B16F10 melanoma with an attenuated <em>Toxoplasma gondii</em> eliminates the treated tumor and stimulates systemic antitumor immunity.
Journal Articles

Avirulent Toxoplasma gondii Generates Therapeutic Antitumor Immunity by Reversing Immunosuppression in the Ovarian Cancer Microenvironment

Jason R. Baird, Barbara A. Fox, Kiah L. Sanders, Patrick H. Lizotte, Juan R. Cubillos-Ruiz, Uciane K. Scarlett, Melanie R. Rutkowski, Jose R. Conejo-Garcia, Steven Fiering, David J. Bzik
Journal: Cancer Research
Cancer Res (2013) 73 (13): 3842–3851.
https://doi.org/10.1158/0008-5472.CAN-12-1974
Published: 30 June 2013
View article titled, Avirulent <em>Toxoplasma gondii</em> Generates Therapeutic Antitumor Immunity by Reversing Immunosuppression in the Ovarian Cancer Microenvironment
Open the PDF for Avirulent <em>Toxoplasma gondii</em> Generates Therapeutic Antitumor Immunity by Reversing Immunosuppression in the Ovarian Cancer Microenvironment in another window
Includes: Supplementary data
Journal Articles

Reprogramming Tumor-Associated Dendritic Cells In Vivo Using miRNA Mimetics Triggers Protective Immunity against Ovarian Cancer

Juan R. Cubillos-Ruiz, Jason R. Baird, Amelia J. Tesone, Melanie R. Rutkowski, Uciane K. Scarlett, Ana L. Camposeco-Jacobs, Jorge Anadon-Arnillas, Noah M. Harwood, Murray Korc, Steven N. Fiering, Lorenzo F. Sempere, Jose R. Conejo-Garcia
Journal: Cancer Research
Cancer Res (2012) 72 (7): 1683–1693.
https://doi.org/10.1158/0008-5472.CAN-11-3160
Published: 01 April 2012
View article titled, Reprogramming Tumor-Associated Dendritic Cells <em>In Vivo</em> Using miRNA Mimetics Triggers Protective Immunity against Ovarian Cancer
Open the PDF for Reprogramming Tumor-Associated Dendritic Cells <em>In Vivo</em> Using miRNA Mimetics Triggers Protective Immunity against Ovarian Cancer in another window
Includes: Supplementary data